Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PRDM16 modulates aspects of cell cycle dynamics and maturation in human iPSC-derived cardiomyocytes.

Stem cell reports·2026

Same author

iPSC-derived modeling of HLA-lacking hematopoiesis reveals clonal diversity in eltrombopag response in acquired aplastic anemia.

Stem cells (Dayton, Ohio)·2026

Same author

NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners.

Leukemia·2026

Same author

Impact of Pulmonary Vein Morphology on the Number of Pulsed Field Ablation Applications Using Circular Multielectrode Catheters.

Journal of cardiovascular electrophysiology·2025

Same author

The isolation, bioactivity, and role of β-glucans in health: A review.

International journal of biological macromolecules·2025

Same author

Integrative Transcriptomic-Histological Analysis in Dilated Cardiomyopathy Unveils FGFR1 Inhibition as Anti-Cardiac Fibrotic and Cardioprotective Therapy.

JACC. Basic to translational science·2025

Search research articles

Related Experiment Video

Updated: Oct 27, 2025

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

Making Cardiomyocytes from Pluripotent Stem Cells.

Peter Karagiannis¹, Yoshinori Yoshida²

¹Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Methods in Molecular Biology (Clifton, N.J.)

|July 24, 2021

Summary

Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) offer promise for heart disease research and therapies. However, challenges remain in optimizing their electromechanical properties, tissue integration, and genetic manipulation for studying heart disorders.

Keywords:

Animal models Assays Cardiomyocytes Gene editing Pluripotent stem cells RNA sequencing

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Related Experiment Videos

Last Updated: Oct 27, 2025

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Area of Science:

Cardiovascular Research
Stem Cell Biology
Regenerative Medicine

Background:

Pluripotent stem cells can differentiate into cardiomyocyte lineages (PSC-CMs).
PSC-CMs are valuable for heart disease modeling, drug discovery, and cell therapies.
Current differentiation protocols require further advancement to realize the full potential of PSC-CMs.

Purpose of the Study:

To address the challenges in deriving and utilizing pluripotent stem cell-derived cardiomyocytes (PSC-CMs).
To outline current methodologies for overcoming obstacles in PSC-CM research and application.
To discuss the potential of PSC-CMs in understanding and treating cardiac disorders.

Main Methods:

Consideration of challenges in PSC-CM differentiation and application.
Review of current methodologies offering partial solutions.
Discussion of strategies for improving electromechanical properties and tissue integration.

Main Results:

Identification of key obstacles in PSC-CM development, including achieving proper electromechanical function and tissue formation.
Exploration of methods for genetic manipulation of PSC-CMs to study disease mechanisms.
Partial solutions and current approaches are presented to address these challenges.

Conclusions:

Further advances in differentiation protocols are crucial for harnessing the therapeutic potential of PSC-CMs.
Overcoming challenges in PSC-CM development will enhance their utility in disease modeling and regenerative medicine.
Continued research is needed to fully integrate PSC-CMs into clinical applications for heart conditions.